IFN-γ plays a unique role in protection against low virulent Trypanosoma cruzi strain

PLoS Neglected Tropical Diseases

Volumn 6, Issue 4, 2012, Pages

  Rodrigues, Adele A ^a   Saosa, Jasson S S ^b,c   da Silva, Grace K ^b   Martins, Flávia A ^a   da Silva, Aline A ^a   da Silva Souza Neto, Cecílio P ^a   Horta, Catarina V ^b   Zamboni, Dario S ^b   da Silva, João S ^b   Ferro, Eloisa A V ^a   da Silva, Claudio V ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSIDAD AUTÓNOMA DE BUCARAMANGA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12P40; INTERLEUKIN 18; MYELOID DIFFERENTIATION FACTOR 88; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TUMOR NECROSIS FACTOR ALPHA;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIVISION; CHAGAS DISEASE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HOST SUSCEPTIBILITY; HUMAN; HUMAN CELL; INFECTION CONTROL; MALE; MORTALITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PARASITE VIRULENCE; PARASITEMIA; PERITONEUM MACROPHAGE; TRYPANOSOMA CRUZI; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; IMMUNOLOGY; MOUSE MUTANT; PATHOGENICITY;

ANIMALS; CHAGAS DISEASE; FEMALE; INTERFERON-GAMMA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PARASITEMIA; TRYPANOSOMA CRUZI;

EID: 84861210567     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001598     Document Type: Article

References (31)

1. Rassi A, Rassi A, Marin-Neto JA, (2010) Chagas disease. The Lancet 375: 1388-1402.
2. Brener Z, Gazzinelli RT, (1997) Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol 114: 103-110.
3. Dos Reis GA, (1997) Cell-mediated immunity in experimental Trypanosoma cruzi infection. Parasitol Today 13: 335-342.
4. Kayama H, Takeda K, (2010) The innate immune response to Trypanosoma cruzi infection. Microbes Infect 12: 511-517.
5. Dos Reis GA, (2011) Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease. Braz J Med Biol Res 44: 84-90.
6. Aliberti JCS, Cardoso MAG, Martins GA, Gazzinelli RT, Vieira LQ, et al. (1996) Interleukin- 12 mediates resistance to Trypanosoma cruzi in mice andis produced by murine macrophages in response to live trypomastigotes. Infection and Immunity 64: 1961-1967.
7. Aliberti JCS, Machado FS, Souto JT, Campanelli AP, Teixeira MM, et al. (1999) β- Chemokines enhance parasite uptake and promote nitricoxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi. Infection and Immunity 67: 4819-4826.
8. Antúnez MI, Cardoni RL, (2000) IL-12 and IFN-γ production, and NK cell activity, in acute and chronic experimental Trypanosoma cruzi infections. Immunology Letters 71: 103-109.
9. Talvani A, Ribeiro CS, Aliberti JC, Michailowsky V, Santos PV, et al. (2000) Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-γ as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes and Infection 2: 851-866.
10. Abrahamsohn IA, Coffman RL, (1996) Trypanosoma cruzi: IL-10, TNF, IFN-γ and IL-12 regulate innate and acquired immunity to infection. Experimental Parasitology 84: 231-244.
11. Rodrigues MM, Ribeirão M, Boscardin SB, (2000) CD4 Th1 but not Th2 clones efficiently activate macrophages to eliminate Trypanosoma cruzi through a nitric oxide dependent mechanism. Immunology Letters 73: 43-50.
12. Hiyama K, Hamano S, Nakamura T, Nomoto K, Tada I, (2001) IL-4 reduces resistance of mice to Trypanosoma cruzi infection. Parasitology Research 87: 269-274.
13. Zingales B, Andrade SG, Briones MR, Campbell DA, Chiari E, et al. (2009) A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends T. cruzi I to TcVI. Mem Inst Oswaldo Cruz 104: 1051-1054.
14. Di Noia JM, Buscaglia CA, De Marchi CR, Almeida IC, Frasch ACC, (2002) A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage. Journal of Experimental Medicine 195: 401-413.
15. Fernandes O, Mangia RH, Lisboa CV, Pinho AP, Morel CM, et al. (1999) The complexity of the sylvatic cycle of Trypanosoma cruzi in Rio de Janeiro state (Brazil) revealed by the non-transcribed spacer of themini-exon gene. Parasitology 118: 161-166.
16. Añez N, Crisante G, da Silva FM, Rojas A, Carrasco H, et al. (2004) Predominance of lineage I among Trypanosoma cruzi isolates from Venezuelan patients with different clinical profiles of acute Chagas' disease. Tropical Medicine and International Health 9: 1319-1326.
17. Black CL, Ocaña S, Riner D, Costales JA, Lascano MS, et al. (2007) Household risk factors for Trypanosoma cruzi seropositivity in two geographic regions of Ecuador. Journal of Parasitology 93: 12-16.
18. Mejía-Jaramillo AM, Peña VH, Triana-Chávez O, (2009) Trypanosoma cruzi: biological characterization of lineages I and II supports the predominance of lineage I in Colombia. Experimental Parasitology 121: 83-91.
19. Yoshida N, (1983) Surface antigens of metacyclic trypomastigotes of Trypanosoma cruzi. Infection and Immunity 40: 836-839.
20. Yoshida N, Blanco SA, Araguth MF, Russo M, González J, (1990) The stage-specific 90-Kilodalton surface antigen of metacyclic trypomastigotes of Trypanosoma cruzi. Mol Biochem Parasitol 39: 39-46.
21. Silva CV, Luquetti AO, Rassi A, Mortara RA, (2006) Involvement of Ssp-4-related carbohydrate epitopes in mammalian cell invasion by Trypanosoma cruzi amastigotes. Microbes and Infection 8: 2120-2129.
22. Silva CV, Kawashita SY, Probst CM, Dallagiovanna B, Cruz MC, et al. (2009) Characterization of a 21 kDa protein from Trypanosoma cruzi associated with mammalian cell invasion. Microbes and Infection 11: 563-570.
23. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A, (1992) The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur J Immunol 22: 2501-2506.
24. Hölscher C, Köhler G, Müller U, Mossmann H, Schaub GA, et al. (1998) Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun 66: 1208-1215.
25. Aliberti JC, Souto JT, Marino AP, Lannes-Vieira J, Teixeira MM, et al. (2001) Modulation of chemokine production and inflammatory responses in interferongamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol 158: 1433-1440.
26. Lykens JE, Terrell CE, Zoller EE, Divanovic S, Trompette A, et al. (2010) Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivo. J Immunol 184: 877-885.
27. Padilla AM, Bustamante JM, Tarleton RL, (2009) CD8+ T cells in Trypanosoma cruzi infection. Curr Opin Immunol 21: 385-390.
28. Bogdan C, (2001) Nitric oxide and the immune response. Nat Immunol 2: 907-916.
29. Gutierrez FRS, Mineo TWP, Pavanelli WR, Guedes PMM, Silva JS, (2009) The effects of nitric oxide on the immune system during Trypanosoma cruzi infection. Mem Inst Oswaldo Cruz 104: 236-245.
30. Gupta S, Dhiman M, Wen JJ, Garg NJ, (2011) ROS signalling of inflammatory cytokines during Trypanosoma cruzi infection. Adv Parasitol 76: 153-70.
31. Santiago HC, Feng CG, Bafica A, Roffe E, Arantes RM, et al. (2005) Mice Deficient in LRG-47 Display Enhanced Susceptibility to Trypanosoma cruzi Infection Associated with Defective Hemopoiesis and Intracellular Control of Parasite Growth. J Immunol 175: 8165-8172.